ALLIANCEBERNSTEIN L.P. - C4 THERAPEUTICS INC ownership

C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 116 filers reported holding C4 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of C4 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$163,280
-46.8%
52,0000.0%0.00%
Q4 2022$306,800
-26.6%
52,000
+9.0%
0.00%
Q3 2022$418,000
+9.1%
47,700
-6.1%
0.00%
Q2 2022$383,000
-89.1%
50,800
-64.9%
0.00%
-100.0%
Q1 2022$3,511,000
+6.3%
144,721
+41.1%
0.00%0.0%
Q4 2021$3,303,000
-9.0%
102,567
+26.3%
0.00%0.0%
Q3 2021$3,628,000
+56.4%
81,197
+32.5%
0.00%0.0%
Q2 2021$2,319,00061,2820.00%
Other shareholders
C4 THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 1,642,210$39,840,0003.87%
Paradigm Biocapital Advisors LP 499,496$12,118,0003.20%
Cypress Point Wealth Management, LLC 118,573$2,877,0002.92%
COMMODORE CAPITAL LP 481,094$11,671,0002.61%
Nextech Invest Ltd. 375,857$9,118,0002.60%
RTW INVESTMENTS, LP 4,531,982$109,946,0002.28%
SPHERA FUNDS MANAGEMENT LTD. 362,528$8,795,0001.24%
Perceptive Advisors 2,082,723$50,526,0001.01%
CLOUGH CAPITAL PARTNERS L P 356,181$8,641,0000.66%
HighVista Strategies LLC 34,760$843,0000.54%
View complete list of C4 THERAPEUTICS INC shareholders